[The heart in systolic hypertension]

Area of Science:

• Cardiology
• Hypertension Research

Context:

• Focuses on two distinct forms of systolic hypertension: primary hyperkinetic heart syndrome and isolated systolic hypertension in the elderly.
• Primary hyperkinetic heart syndrome involves overactivity of cardiac beta-receptors in younger individuals.
• Systolic hypertension in the elderly is attributed to arterial capacitance loss.

Purpose:

• To differentiate primary hyperkinetic heart syndrome from other hypertensive conditions.
• To explore the effects and implications of beta-adrenergic blockade in hyperkinetic heart syndrome.
• To analyze the mechanisms behind isolated systolic hypertension in older adults.

Summary:

• Beta-adrenergic blockade effectively normalizes systolic hypertension, high cardiac output, and ECG repolarization variability in primary hyperkinetic heart syndrome.
• Long-term beta-blockade does not induce elevated systemic vascular resistance or ventricular hypertrophy despite adrenergic stimulation.
• Systolic hypertension in the elderly results from arterial capacitance loss, impacting left ventricular diastolic function.

Impact:

• Establishes high cardiac output as a cause of systolic hypertension.
• Demonstrates that beta-blockade is a symptomatic treatment, not a cure, for hyperkinetic heart syndrome.
• Provides insights into the pathophysiology of aging-related arterial stiffening and its hemodynamic consequences.